Exfoliative dermatitis - Dermatitis Exfoliative
☆ AI Dermatology — Free Service
Yng nghanlyniadau Stiftung Warentest 2022 o’r Almaen, roedd boddhad defnyddwyr â ModelDerm ond ychydig yn is nag ymgynghoriadau telefeddygaeth taledig.
Yng nghanlyniadau Stiftung Warentest 2022 o’r Almaen, roedd boddhad defnyddwyr â ModelDerm ond ychydig yn is nag ymgynghoriadau telefeddygaeth taledig.
Red (burning) Skin Syndrome – mae erythema a graddfa ar y corff cyfan yn brif symptom Dermatitis Exfoliative (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesMae Erythroderma yn gyflwr croen prif ond difrifol. Er bod yr union achos yn aml yn anhysbys, gall gael ei sbarduno gan adwaith cyffuriau neu gan ganswr sylfaenol. Un cancer cyffredin sy'n gysylltiedig â dermatitis exfoliative yw lymffoma celloedd T y croen, na fydd yn dangos symptomau am fisoedd neu hyd yn oed flynyddoedd ar ôl i'r cyflwr croen ddechrau. Fel arfer, mae angen mynd i'r ysbyty ar gyfer asesiad cychwynnol a thriniaeth. Yn gyffredinol, mae gan gleifion â chlefydau a achosir gan gyffuriau ragolygon hirdymor da, er bod achosion heb achos clir yn tueddu i fod â chwrs cylchol a chylchol. Mae'r prognosis ar gyfer achosion sy'n gysylltiedig â cancer fel arfer yn dibynnu ar sut mae'r cancer yn datblygu.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Yn nodweddiadol, mae'n dangos cochni eang a fflawio sy'n gorchuddio dros 90% o'r corff. Mae'r cyflwr hwn yn arwydd gweladwy o faterion iechyd sylfaenol amrywiol fel soriasis, ecsema, neu ymateb i rai meddyginiaethau.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Y prif achos o erythroderma yw gwaethygu clefyd croen gwaelodol, megis soriasis, dermatitis cyswllt, dermatitis seborrheic, planws cen, pityriasis rubra pilaris, neu adwaith i feddyginiaeth, megis defnyddio steroidau argroenol. Mae'r maniffest sylfaenol yn llai aml ac fe'i gwelir fel arfer mewn achosion o lymffoma celloedd T croenol. Gan fod angen ei wahaniaethu oddi wrth lymffoma celloedd T croenol, mae biopsi'n cael ei wneud.